首页 › 基金 › Commodore Capital LP › SRZN

Commodore Capital LP 对 SRZN 的持仓历史

SURROZEN INC · 医疗保健

Commodore Capital LP 在 Q3 2026 的 13F 申报中披露持有 SRZN(SURROZEN INC)885,000 股,市值约 US$28.5M,约占其申报组合的 2.21%,在其申报持仓中市值排名第 13 位。 Commodore Capital LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)885.00K 股
申报持仓市值$28.48M
组合权重2.21%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Commodore Capital LP 对 SRZN 的持仓演变

Commodore Capital LP 于 Q3 2026 首次披露 SRZN 持仓:885,000 股(约 US$28.5M)。

逐季持仓明细

季度股数金额变化
Q3 2026 885.00K $28.48M 新进

关于 SRZN 与 13F 数据

SRZN(SURROZEN INC)属于医疗保健行业。我们追踪的基金中还有 59 只申报持有 SRZN,申报仓位最大的包括:Column Group LLC (US$76.6M), Boxer Capital Management, LLC (US$43.8M), Venrock Adviser, LLC (US$20.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SRZN 的基金

查看 SRZN 的全部基金持有人 →

常见问题

How long has Commodore Capital LP held SRZN?

Commodore Capital LP has disclosed SRZN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Commodore Capital LP's current position in SRZN?

As of Q3 2026, Commodore Capital LP holds 885.00K shares of SRZN (SURROZEN INC), valued at $28.48M, representing 2.21% of its reported portfolio and ranking #13.

Has Commodore Capital LP been buying or selling SRZN?

In the latest 13F filing (Q3 2026), Commodore Capital LP newly opened its position in SRZN.

Which other funds hold SRZN?

Other major institutional holders of SRZN include Column Group LLC, Boxer Capital Management, LLC, Venrock Adviser, LLC, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.